-
UCB Trial Achieves Endpoints
ContractPharma
December 11, 2019
Phase III study met its co-primary and secondary endpoints demonstrating superiority of bimekizumab to Abbvie’s Humira in plaque psoriasis
-
Erenumab migraine drug fails to meet NICE recommendation standards
europeanpharmaceuticalreview
September 27, 2019
NICE has announced that it will not be recommending erenumab, an injectable migraine treatment, due to issues with cost and its long-term effectiveness.
-
Global injectable drug delivery market predicted to grow 12.8 percent
europeanpharmaceuticalreview
September 26, 2019
Increasing demand for convenient drug delivery, as well as an increase in diseases such as diabetes, has fuelled the global injectable drug delivery market.
-
Losartan drug recall expanded to include five more lots
europeanpharmaceuticalreview
September 26, 2019
FDA announces the voluntary recall for the losartan medications has been extended to include more lots, after impurities were found in the drugs.
-
Omega Therapeutics launches with focus on epigenetic drugs
pharmaceutical-technology
September 25, 2019
US-based Flagship Pioneering has launched a genomics medicine company, Omega Therapeutics, to develop drugs that will leverage the human genome to cure or treat various diseases.
-
EC Grants Orphan Drug Designation for Nirogacestat for Soft Tissue Sarcoma
americanpharmaceuticalreview
September 25, 2019
SpringWorks Therapeutics announced the European Commission has granted Orphan Drug Designation for nirogacestat, an oral, selective, small molecule, gamma-secretase inhibitor, for the treatment of soft tissue sarcoma.
-
Leukemia drug shows promise for treating a childhood brain cancer
worldpharmanews
September 25, 2019
A drug used to treat chronic myeloid leukemia appears to be more effective at stopping a type of medulloblastoma in mouse models than existing treatments for the deadly pediatric brain tumor ...
-
More Blood Pressure Drugs Recalled
drugs
September 25, 2019
The recall of the commonly prescribed blood pressure drug losartan has been expanded once again to include an additional five lots.
-
FDA Grants Orphan Drug Designation to Reneo for REN001
americanpharmaceuticalreview
September 23, 2019
Reneo Pharmaceuticals announced the U.S. Food and Drug Administration (FDA) Office of Orphan Products Development has granted Orphan Drug Designation to the company's lead drug candidate ...
-
Drones set to deliver drugs to remote parts of India by 2020
europeanpharmaceuticalreview
September 23, 2019
The government of an Indian province and a US company have teamed together in an initiative to deliver medications to remote regions using drones, which should begin next year.